8.32
Sensei Biotherapeutics Inc (SNSE) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2025-06-30 | 2025-03-31 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
-
|
- | - | - | - |
Operating Expenses |
28.43%
5.206
|
7.274 | 7.787 | 8.73 | 8.142 |
Interest Income/Expense |
23.08%
0.01
|
0.013 | 0.024 | 0.028 | 0.031 |
Operating Income/Loss |
28.43%
-5.206
|
-7.274 | -7.787 | -8.73 | -8.142 |
Income/Loss From Continuing Operations Before Tax |
28.09%
-4.936
|
-6.864 | -7.142 | -7.992 | -17.30 |
Income Tax Expense/Benefit |
-
|
- | - | - | -9.89 |
Income/Loss From Continuing Operations After Tax |
28.09%
-4.936
|
-6.864 | -7.142 | -7.992 | -7.414 |
|
28.09%
-4.936
|
-6.864 | -7.142 | -7.992 | -7.414 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
95.00%
1.2609
|
25.19 | 25.10 | 25.05 | -0.9899 |
Diluted Average Shares |
95.00%
1.2609
|
25.19 | 25.10 | 25.05 | -0.9899 |
Basic Earnings Per Share |
1,348%
-3.91
|
-0.27 | -0.28 | -0.32 | -0.30 |
Diluted Earnings Per Share |
1,348%
-3.91
|
-0.27 | -0.28 | -0.32 | -0.30 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):